Back
Ligand Pharmaceuticals Vs. Pieris Pharmaceuticals Industry Stock Comparison
Buy
60
LGND
Ligand Pharmaceuticals
Last Price:
114.04
Seasonality Move:
12.9%
Sell
45
PIRS
Pieris Pharmaceuticals
Last Price:
16.88
Seasonality Move:
9.58%
Buy
60
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $111.13. The Score for LGND is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Pieris Pharmaceuticals (PIRS)
is a Sell
Is Pieris Pharmaceuticals a Buy, Sell or Hold?
- The current Pieris Pharmaceuticals [PIRS] share price is $17.00. The Score for PIRS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- PIRS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $111.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
PIRS Stock Price Chart
What is Pieris Pharmaceuticals's stock price today?
-
The Pieris Pharmaceuticals share price today is $17.00
The current trend is moderately bullish and PIRS is experiencing slight selling pressure.
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.11 | Buy |
| Relative Strength Index (14 RSI): | 57.9 | Buy |
| Chaikin Money Flow: | 62382 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (102.29 - 110.57) | Buy |
| Bollinger Bands (100): | (91.02 - 108.76) | Buy |
PIRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 53.98 | Buy |
| Chaikin Money Flow: | -5122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.31 - 17.01) | Buy |
| Bollinger Bands (100): | (10.79 - 18.43) | Buy |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.95 | Buy |
| 20-day SMA: | 107.48 | Buy |
| 50-day SMA: | 104.59 | Buy |
| 200-day SMA: | 88.4 | Buy |
| 8-day EMA: | 109.98 | Buy |
| 20-day EMA: | 108.03 | Buy |
| 50-day EMA: | 104.74 | Buy |
| 200-day EMA: | 91.45 | Buy |
PIRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.01 | Sell |
| 20-day SMA: | 16.76 | Buy |
| 50-day SMA: | 16.86 | Buy |
| 200-day SMA: | 13.67 | Buy |
| 8-day EMA: | 16.99 | Buy |
| 20-day EMA: | 16.84 | Buy |
| 50-day EMA: | 16.41 | Buy |
| 200-day EMA: | 17.6 | Sell |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.84 per share.
Pieris Pharmaceuticals Earnings Growth & PIRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.09 per share.
Ligand Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pieris Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||